For The Better

British American Tobacco made a major admission in 2023, and it says a great deal about the future of cigarettes in the U.S. market.

If you’re looking for something simple and reliable for a start-out amount of money, there’s an obvious name hiding in plain sight.

Here’s how much of a raise you might receive next year.

Despite the stock’s struggles, this business has exhibited steady growth.

Should investors continue to hold on to the stock?

These stocks have been underwhelming investments this year, but in the long run, they may prove to be excellent buys.

There’s a silver lining to closing down its other restaurant concept.

The Nasdaq Composite sets a high bar, but the Invesco QQQ ETF is up to the challenge.

It took a long time, but ExxonMobil is finally trading at all-time highs.

Don’t try to time the market. Buy and hold these ETFs instead.

This passive income investor dream stock generates the strongest operating profit margin of any company I follow.

For less than $2,500, you could own one share of each “Magnificent Seven” stock.

Wall Street isn’t happy with SoFi right now, but investors should be.

Brookfield Infrastructure will play a key role in supporting the AI and digitalization megatrends.

It’s a problem but one you can overcome with the right strategy.

Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.

MPLX is a well-oiled cash-producing machine.

These picks offer a window into Druckenmiller’s insights and mistakes.

Putting your money into a Roth IRA could be one of the best financial decisions you’ll make.

These stocks aren’t household names but could be big winners for patient investors.